CHEMIGRAN derived from the words "chemi" and "gran" to find a marketing space in the segment of "grand chemicals" in March 1993.

Since then, CHEMIGRAN has evolved into a marketing and research organization in the niche segmentation of API of the Pharmaceutical Science in Oncology.

Cancer is typically an aging disease that corresponds to the accelerating aging population globally ( Population Reference Bureau, 2007 ).  With 10-15 millions of new cancer incidence emerging each year (WHO, 2008) the burden of treatment cost will remain a growing pain.  In a recent US National Survey of July 2009, it has been found that the fear and concern of cost of treatment is higher than the death from cancer ( Community Oncology Alliance, 2009 ).